Retrospective Review of DTG/3TC Versus BIC/F/TAF Across a Multi Clinic Infectious Disease Organization in Southeast United States

Inclusion Criteria: * Adults, aged 18 years and older; * Diagnosis of HIV-1; * Have a history of ART consisting of DTG/3TC or BIC/F/TAF, initiated from May 1, 2019 through January 28, 2023; * Have at least 48 weeks of clinical follow up after initiation of DTG/3TC or BIC/F/TAF; clinical follow-up can include time post-discontinuation of either index regimen; * Complete data, for HIV-1 RNA viral load at all study time points, including baseline, through 24 weeks and through 48 weeks; * Received care from a physician, nurse practitioner or physician assistant at the organization Exclusion Criteria: * Index regimen is BIC/F/TAF and has a history of ART consisting of DTG+3TC or DTG/3TC; * Index regimen is DTG/3TC and has a history of ART consisting of BIC/F/TAF